December 18, 2019 by Bill Schiffner
AARP, Governor Cuomo
Leading Headlines, Pharmacy

ALBANY, N.Y. – AARP New York State Director Beth Finkel on Wednesday released the following statement about Governor Andrew Cuomo’s three-part proposal to crack down on drug companies’ high prices: “AARP launched a nationwide “Stop Rx Greed” campaign earlier this year, and we are fully supportive of Governor Cuomo’s comprehensive, multi-pronged proposal to attack the skyrocketing costs
November 11, 2019 by Chain Drug Review
AARP, Governor Andrew Cuomo
Leading Headlines, Pharmacy

ALBANY, N.Y. — A broad coalition of organizations representing New York patients, consumers and workers are urging Governor Andrew Cuomo to support a comprehensive policy package to address the high cost of prescription drugs in the next Executive Budget. To date, no governor in the nation has proposed and advocated for a comprehensive prescription drug
October 16, 2019 by Chain Drug Review
AARP, beauty, Image and Media, Mirror/Mirror: Survey of Women's Reflections of Beauty
Business, Leading Headlines

WASHINGTON — A national survey of nearly 2,000 U.S. women finds a significant number of respondents in their 50s and above feel ignored by the beauty and personal grooming products industries, AARP reported, upon the release of Mirror/Mirror: Survey of Women’s Reflections of Beauty, Image and Media. Forty percent of Gen-X women (ages 39-54) and
December 8, 2017 by Chain Drug Review
AARP, AARP Public Policy Institute, Debra Whitman, Leigh Purvis, prescription drug retail pricing, retail prices for prescription drugs, Retail Prices of Prescription Drugs Widely Used by Older Americans, Rx Price Watch Report
Featured Articles, Leading Headlines, Pharmacy, Retail News

WASHINGTON — Retail prices for prescription drugs widely used by older Americans have risen more than 50 times faster than the inflation rate, an AARP analysis found. For 768 prescription drugs commonly used by older adults, retail prices surged an average of 6.4% in 2015, outpacing the general inflation rate of 0.1%, according to the
September 8, 2017 by Chain Drug Review
AARP, AARP Public Policy Institute, cost of generic drug therapy, cost of specialty drug therapy, Debra Whitman, generic drug price increases, Leigh Purvis, retail prices for specialty drugs
Featured Articles, Leading Headlines, Pharmacy, Retail News

WASHINGTON — Retail prices for specialty drugs widely used by older Americans has surged, while pricing for generic drugs has dipped despite sharp hikes for some medications, according to a pair of new AARP Public Policy Institute (PPI) reports. For the specialty drugs examined in the study, retail prices jumped by an average of 9.6%
December 14, 2016 by Chain Drug Review
AARP, AARP Public Policy Institute, brand-name drug pricing, branded prescription drugs, Debra Whitman, Leigh Purvis, retail prices of brand name prescription drugs, Rx Price Watch Report
Leading Headlines, Pharmacy, Supplier News

WASHINGTON — Retail prices for 268 branded prescription drugs widely used by older Americans climbed by an average of 15.5% in 2015, according to a new report by the AARP Public Policy Institute. AARP said Wednesday that the gain in branded drug prices was nearly 130 times faster than the 0.1% inflation rate and marked
November 9, 2015 by Brian Bossetta and Chain Drug Review
2016 federal budget, AARP, Jo Ann Jenkins, Medicare Part B
2015, Issue 11-09-2015, Issues, News
WASHINGTON — The nation’s most prominent lobbying group for seniors is backing the 2016 federal budget deal reached in Congress. In a letter to Congress praising the deal, AARP’s chief executive officer, Jo Ann Jenkins, wrote, “Your efforts to reach across the aisle and together find sensible solutions to significant problems are appreciated and commended.”